Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3466-3471

  Van Der Pol, Barbara ^a   Warren, Terri ^b   Taylor, Stephanie N ^c   Martens, Mark ^d   Jerome, Keith R ^e   Mena, Leandro ^f   Lebed, Joel ^g   Ginde, Savita ^h   Fine, Paul ⁱ   Hook III, Edward W ^j  

^a INDIANA UNIVERSITY   (United States)

^b Westover Heights Clinic   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF MISSISSIPPI   (United States)

^g Planned Parenthood Southeastern Pennsylvania   (United States)

^h Planned Parenthood of the Rocky Mountains   (United States)

ⁱ Planned Parenthood Gulf Coast   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEVICE APPROVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; GENITAL HERPES; HEALTH CARE FACILITY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; UNITED STATES; VIRUS CULTURE; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; UNITED STATES; YOUNG ADULT;

EID: 84867516727     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01685-12     Document Type: Article

References (17)

1. Baeten JM, et al. 2008. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J. Infect. Dis. 198:1804-1808.
2. Baughman AL, et al. 2008. Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin. Vaccine Immunol. 15:106-114. (Pubitemid 351966543)
3. Benedetti J, Corey L, Ashley R. 1994. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 121:847-854.
4. Cattamanchi A, et al. 2008. Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system. Clin. Vaccine Immunol. 15: 1638-1643.
5. Centers for Disease Control and Prevention. 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb. Mortal. Weekly Rep. 59:1-112.
6. Corey L, Huang M, Selke S, Wald A. 2005. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time Taqman PCR assay. J. Med. Virol. 76:350-355. (Pubitemid 40770890)
7. Crist GA, Langer JM, Woods GL, Procter M, Hillyard DR. 2004. Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens. Diagn. Microbiol. Infect. Dis. 49:173-177. (Pubitemid 38891723)
8. Engelberg P, Carrell D, Krantz E, Corey L, Wald A. 2003. Natural history of genital herpes simplex virus type 1 infection. Sex. Transm. Dis. 30:174-177. (Pubitemid 36184367)
9. Fleming DT, et al. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105-1111. (Pubitemid 27444100)
10. Hobbs MM, et al. 2008. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex. Transm. Dis. 35:8-13. (Pubitemid 351619345)
11. Jerome K, Huang M-L, Wald A, Selke S, Corey L. 2002. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time polymerase chain reaction. J. Clin. Microbiol. 40:2609-2611. (Pubitemid 34747371)
12. Langenberg AGM, et al. 1999. A prospective study of infections with herpes simplex virus type 1 and 2. N. Engl. J. Med. 341:1432-1438. (Pubitemid 29513459)
13. Mertz KJ, et al. 1998. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. J. Infect. Dis. 178:1795-1798. (Pubitemid 28558157)
14. Taylor SN, et al. 2011. Clinical evaluation of the BD ProbeTec(TM) Chlamydia trachomatis Qx Amplified DNA Assay on the BD Viper System with XTR technology. Sex. Transm. Dis. 38:603-609.
15. Tronstein E, et al. 2011. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305:1441-1449.
16. Wald A, Huang M, Selke S. 2003. Polymerase chain reaction for detection of herpes simplex virus (HSV) on mucosal surfaces: comparison withHSV isolation in cell culture. J. Infect. Dis. 188:1345-1351. (Pubitemid 37433705)
17. Xu F, et al. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964-973. (Pubitemid 44285373)